Hierfür ist eine Anmeldung erforderlich. Bitte registrieren Sie sich bei uns oder melden Sie sich mit Ihren Zugangsdaten an.

IRF5 gene

Last updated on: 11.04.2025

Dieser Artikel auf Deutsch

Definition
This section has been translated automatically.

The IRF5 gene (IRF5 stands for: Interferon Regulatory Factor 5) is a protein-coding gene located on chromosome 7q32.1. The signaling pathways associated with this gene include the Toll-like receptor 7/8 (TLR7/8) cascade and the Toll-like receptor signaling pathway. The use of alternative promoters and alternative splicing lead to several transcript variants, and a 30-nt indel polymorphism (SNP rs60344245) can result in the loss of a 10-aa segment. An important paralog of this gene is IRF6.

General information
This section has been translated automatically.

The IRF6 gene encodes a member of the interferon-regulatory factor (IRF) family, a group of transcription factors with diverse functions, including virus-mediated activation of interferon and modulation of cell growth, differentiation, apoptosis and immune system activity. The encoded IRF5 protein is a transcription factor that plays a critical role in innate immunity by regulating the expression of type I interferon (IFN) IFN-alpha and INF-beta as well as inflammatory cytokines downstream of endolysosomal toll-like receptors TLR7, TLR8 and TLR9 (Barnes BJ et al. 2001; Schoenemeyer A et al. 2005). IRF3 and IRF7 genes are activated in response to a variety of viruses or after activation of Toll-like receptors (TLR) 3 and TLR4 by double-stranded RNA and lipopolysaccharide, respectively.

The activation of IRF5 is much more limited. In contrast to IRF3 and IRF7, IRF5 is not a target of the TLR3 signaling pathway, but the gene is activated by TLR7 or TLR8 signals. Activation of IRF5 and IRF7 requires MyD88, interleukin-1 receptor-associated kinase 1 and tumor necrosis factor receptor-associated factor 6.

Ectopic expression of IRF5 enables the production of type I interferons in response to TLR7 signaling, whereas silencing of IRF5 by small interfering RNA reduces the induction of type I interferon in response to the TLR7 ligand R-848. IRF5 and IRF7 have been shown to be important mediators of TLR7 signaling (Schoenemeyer A et al. 2005). Regulates the transcription of type I IFN genes (IFN-alpha and IFN-beta) and IFN-stimulated genes (ISG) by binding to an interferon-stimulated response element (ISRE) in their promoters. IFR5 is the main transcription factor regulating the IFN response during SARS-CoV-2 infection (Yin X et al. 2021).

Clinic
This section has been translated automatically.

Diseases associated with IRF5 include chronic inflammatory bowel disease and systemic lupus erythematosus.

Literature
This section has been translated automatically.

  1. Barnes BJ et al. (2001) Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes. J Biol Chem 276:23382-23390.
  2. Lopez-Pelaez M et al. (2014) Protein kinase IKKβ-catalyzed phosphorylation of IRF5 at Ser462 induces its dimerization and nuclear translocation in myeloid cells. Proc Natl Acad Sci U S A 111:17432-17437.
  3. Schoenemeyer A et al. (2005) The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling. J Biol Chem 280:17005-17012.
  4. Yin X et al. (2021) MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells. Cell Rep 34:108628.

Last updated on: 11.04.2025